Revvity, Inc.
RVTY- Exchange
- NYSE
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0000031791
In the last 90 days, Revvity, Inc. insiders filed 0 open-market purchases and 3 sales; 611 institutions reported holding it in 13F filings for Q3 2026, worth $17.1B in total; Maverick Capital is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 11, 2026, 1:10 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 28, 2025 | Dec 29, 2024 | Dec 31, 2023 | Jan 1, 2023 | Jan 2, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Jan 13, 2025 | Jan 9, 2024 | Jan 9, 2023 | Jan 11, 2022 |
| Revenue | $2.86B | $2.76B | $2.75B | $3.31B | $5.07B |
| Gross profit | – | – | – | $1.99B | – |
| Research and development | $215.8M | $196.8M | $216.6M | $221.6M | $275.0M |
| Selling, general and administrative | $991.9M | $994.1M | $1.02B | $1.03B | $1.23B |
| Operating income | $356.6M | $346.7M | $300.6M | $742.7M | $1.33B |
| Income tax | $28.4M | $33.1M | $3.47M | $139.2M | $336.6M |
| Net income | $241.2M | $270.4M | $693.1M | $569.2M | $943.2M |
| EPS, basic | $2.07 | $2.21 | $5.56 | $4.51 | $8.12 |
| EPS, diluted | $2.07 | $2.20 | $5.55 | $4.50 | $8.08 |
| Weighted shares, basic | 116.5M | 122.8M | 124.7M | 126.2M | 116.2M |
| Weighted shares, diluted | 116.6M | 122.8M | 124.8M | 126.4M | 116.7M |
| Margins and growth | |||||
| Gross margin | – | – | – | 60.1% | – |
| Operating margin | 12.5% | 12.6% | 10.9% | 22.4% | 26.3% |
| Net margin | 8.4% | 9.8% | 25.2% | 17.2% | 18.6% |
| Revenue growth, year over year | +3.7% | +0.2% | −16.9% | −34.6% | +34.0% |
| Net income growth, year over year | −10.8% | −61.0% | +21.8% | −39.7% | +29.6% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 28, 2025 | Dec 29, 2024 | Dec 31, 2023 | Jan 1, 2023 | Jan 2, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Jan 13, 2025 | Jan 9, 2024 | Jan 9, 2023 | Jan 11, 2022 |
| Cash and equivalents | $919.9M | $1.16B | $913.2M | $454.4M | $618.3M |
| Short-term investments | – | $0 | $689.9M | – | – |
| Accounts receivable | $744.7M | $632.4M | $632.8M | $612.8M | $1.02B |
| Inventory | $379.5M | $367.6M | $428.1M | $405.5M | $624.7M |
| Total current assets | $2.24B | $2.35B | $3.00B | $3.29B | $2.44B |
| Property, plant and equipment | $479.2M | $482.2M | $509.7M | $482.9M | $545.6M |
| Goodwill | $6.61B | $6.46B | $6.53B | $6.48B | $7.42B |
| Intangible assets | $2.35B | $2.64B | $3.02B | $3.38B | $4.06B |
| Total assets | $12.2B | $12.4B | $13.6B | $14.1B | $15.0B |
| Accounts payable | $185.5M | $167.5M | $204.1M | $272.8M | $355.5M |
| Short-term debt | $588.8M | $242.0K | $721.9M | $470.9M | – |
| Total current liabilities | $1.33B | $653.1M | $1.45B | $1.54B | $1.21B |
| Long-term debt | $2.63B | $3.15B | $3.18B | $3.92B | $4.98B |
| Total liabilities | $4.92B | $4.73B | $5.69B | $6.75B | $7.86B |
| Shareholders' equity | $7.25B | $7.67B | $7.87B | $7.38B | $7.14B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 28, 2025 | Dec 29, 2024 | Dec 31, 2023 | Jan 1, 2023 | Jan 2, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Jan 13, 2025 | Jan 9, 2024 | Jan 9, 2023 | Jan 11, 2022 |
| Operating cash flow | $582.9M | $628.3M | $91.3M | $679.8M | $1.41B |
| Capital expenditures | $73.5M | $86.6M | $81.4M | $85.6M | $99.9M |
| Free cash flow | $509.4M | $541.7M | $9.90M | $594.2M | $1.31B |
| Depreciation and amortization | $405.3M | $427.8M | $431.8M | $427.0M | $358.0M |
| Stock-based compensation | $22.8M | $37.8M | $41.4M | $51.5M | $32.8M |
| Dividends paid | $32.8M | $34.5M | $35.0M | $35.3M | $32.4M |
| Share buybacks | $820.8M | $369.6M | $388.9M | $80.6M | $73.1M |
| Investing cash flow | -$17.4M | $776.2M | $1.31B | -$132.9M | -$4.11B |
| Financing cash flow | -$857.5M | -$1.13B | -$947.1M | -$661.8M | -$2.94B |
| Net change in cash | -$243.4M | $250.1M | $443.6M | -$148.6M | $216.7M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.8% | 1.4% | 1.5% | 1.6% | 0.6% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 6, 2026 | 111.6M | −1.5% | SEC |
| Aug 6, 2026 | 111.6M | −3.9% | SEC |
| May 8, 2026 | 111.6M | −5.4% | SEC |
| Feb 20, 2026 | 111.8M | −7.0% | SEC |
| Oct 31, 2025 | 113.4M | −6.8% | SEC |
| Aug 1, 2025 | 116.1M | −5.9% | SEC |
| May 2, 2025 | 117.9M | −4.5% | SEC |
| Feb 21, 2025 | 120.2M | −2.7% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.